These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33972400)

  • 21. CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.
    Shimura H; Schwartz D; Gygi SP; Kosik KS
    J Biol Chem; 2004 Feb; 279(6):4869-76. PubMed ID: 14612456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cereblon Promotes the Ubiquitination and Proteasomal Degradation of Interleukin Enhancer-Binding Factor 2.
    Lian Q; Gao Y; Li Q; He X; Jiang X; Pu Z; Xu G
    Protein J; 2020 Oct; 39(5):411-421. PubMed ID: 33009960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bidirectional interplay of HSF1 degradation and UPR activation promotes tau hyperphosphorylation.
    Kim E; Sakata K; Liao FF
    PLoS Genet; 2017 Jul; 13(7):e1006849. PubMed ID: 28678786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imbalance of Hsp70 family variants fosters tau accumulation.
    Jinwal UK; Akoury E; Abisambra JF; O'Leary JC; Thompson AD; Blair LJ; Jin Y; Bacon J; Nordhues BA; Cockman M; Zhang J; Li P; Zhang B; Borysov S; Uversky VN; Biernat J; Mandelkow E; Gestwicki JE; Zweckstetter M; Dickey CA
    FASEB J; 2013 Apr; 27(4):1450-9. PubMed ID: 23271055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tau phosphorylation and aggregation as a therapeutic target in tauopathies.
    Badiola N; Suárez-Calvet M; Lleó A
    CNS Neurol Disord Drug Targets; 2010 Dec; 9(6):727-40. PubMed ID: 20942789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo evidence of CHIP up-regulation attenuating tau aggregation.
    Sahara N; Murayama M; Mizoroki T; Urushitani M; Imai Y; Takahashi R; Murata S; Tanaka K; Takashima A
    J Neurochem; 2005 Sep; 94(5):1254-63. PubMed ID: 16111477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploiting ubiquitin ligase cereblon as a target for small-molecule compounds in medicine and chemical biology.
    Ito T; Yamaguchi Y; Handa H
    Cell Chem Biol; 2021 Jul; 28(7):987-999. PubMed ID: 34033753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon.
    Akuffo AA; Alontaga AY; Metcalf R; Beatty MS; Becker A; McDaniel JM; Hesterberg RS; Goodheart WE; Gunawan S; Ayaz M; Yang Y; Karim MR; Orobello ME; Daniel K; Guida W; Yoder JA; Rajadhyaksha AM; Schönbrunn E; Lawrence HR; Lawrence NJ; Epling-Burnette PK
    J Biol Chem; 2018 Apr; 293(16):6187-6200. PubMed ID: 29449372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The CB
    Costas-Insua C; Hermoso-López A; Moreno E; Montero-Fernández C; Álvaro-Blázquez A; Maroto IB; Sánchez-Ruiz A; Diez-Alarcia R; Blázquez C; Morales P; Canela EI; Casadó V; Urigüen L; Perea G; Bellocchio L; Rodríguez-Crespo I; Guzmán M
    EMBO Mol Med; 2024 Apr; 16(4):755-783. PubMed ID: 38514794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of a human induced pluripotent stem cell-based model for tauopathies combining three microtubule-associated protein TAU mutations which displays several phenotypes linked to neurodegeneration.
    García-León JA; Cabrera-Socorro A; Eggermont K; Swijsen A; Terryn J; Fazal R; Nami F; Ordovás L; Quiles A; Lluis F; Serneels L; Wierda K; Sierksma A; Kreir M; Pestana F; Van Damme P; De Strooper B; Thorrez L; Ebneth A; Verfaillie CM
    Alzheimers Dement; 2018 Oct; 14(10):1261-1280. PubMed ID: 30036493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4(CRBN.).
    Gandhi AK; Kang J; Havens CG; Conklin T; Ning Y; Wu L; Ito T; Ando H; Waldman MF; Thakurta A; Klippel A; Handa H; Daniel TO; Schafer PH; Chopra R
    Br J Haematol; 2014 Mar; 164(6):811-21. PubMed ID: 24328678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models.
    Silva MC; Ferguson FM; Cai Q; Donovan KA; Nandi G; Patnaik D; Zhang T; Huang HT; Lucente DE; Dickerson BC; Mitchison TJ; Fischer ES; Gray NS; Haggarty SJ
    Elife; 2019 Mar; 8():. PubMed ID: 30907729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies.
    Caccamo A; Magrì A; Medina DX; Wisely EV; López-Aranda MF; Silva AJ; Oddo S
    Aging Cell; 2013 Jun; 12(3):370-80. PubMed ID: 23425014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuron-selective toxicity of tau peptide in a cell culture model of neurodegenerative tauopathy: essential role for aggregation in neurotoxicity.
    Zhao K; Ippolito G; Wang L; Price V; Kim MH; Cornwell G; Fulenchek S; Breen GA; Goux WJ; D'Mello SR
    J Neurosci Res; 2010 Nov; 88(15):3399-413. PubMed ID: 20882568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heat shock protein 70 prevents both tau aggregation and the inhibitory effects of preexisting tau aggregates on fast axonal transport.
    Patterson KR; Ward SM; Combs B; Voss K; Kanaan NM; Morfini G; Brady ST; Gamblin TC; Binder LI
    Biochemistry; 2011 Nov; 50(47):10300-10. PubMed ID: 22039833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic suppression of β2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies.
    Wisely EV; Xiang YK; Oddo S
    Hum Mol Genet; 2014 Aug; 23(15):4024-34. PubMed ID: 24626633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of neuronal microtubule dynamics by tau: Implications for tauopathies.
    Venkatramani A; Panda D
    Int J Biol Macromol; 2019 Jul; 133():473-483. PubMed ID: 31004638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypnotic effect of thalidomide is independent of teratogenic ubiquitin/proteasome pathway.
    Hirose Y; Kitazono T; Sezaki M; Abe M; Sakimura K; Funato H; Handa H; Vogt KE; Yanagisawa M
    Proc Natl Acad Sci U S A; 2020 Sep; 117(37):23106-23112. PubMed ID: 32848052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies.
    Xia Y; Prokop S; Gorion KM; Kim JD; Sorrentino ZA; Bell BM; Manaois AN; Chakrabarty P; Davies P; Giasson BI
    Acta Neuropathol Commun; 2020 Jun; 8(1):88. PubMed ID: 32571418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease.
    Chiasseu M; Alarcon-Martinez L; Belforte N; Quintero H; Dotigny F; Destroismaisons L; Vande Velde C; Panayi F; Louis C; Di Polo A
    Mol Neurodegener; 2017 Aug; 12(1):58. PubMed ID: 28774322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.